FDA product code QVQ: Extravascular Support For An Arteriovenous Fistula For Vascular Access

QVQ is the FDA product code for extravascular support for an arteriovenous fistula for vascular access. It is a Class II device, regulated under 21 CFR 870.4600 and reviewed by the Cardiovascular panel. FDA has cleared 2 510(k) submissions under QVQ, 2 in the last five years, from 2 different applicants. The average 510(k) review took 30 days (median 30); 30 days on average over the last three years. 1 De Novo request was granted under it.

Definition

This device is a permanent implant which is surgically placed outside and/or around an artery and/or vein to provide external support to arteriovenous fistulas created for vascular access by means of vascular surgery.

Classification

FieldValue
Device nameExtravascular Support For An Arteriovenous Fistula For Vascular Access
Device classClass II
Regulation21 CFR 870.4600
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)
ImplantYes

510(k) clearances per year for QVQ

YearClearancesAvg. review days
2024131
2026129

Compare with all 510(k) review times · Search every QVQ clearance

Top QVQ applicants

ApplicantClearancesLatest
Laminate Medical Technologies12026-10-29
Laminate Medical Technologies , Ltd.12024-02-16

Most recent QVQ clearances

510(k)ApplicantDeviceDecision dateReview days
K263598Laminate Medical TechnologiesVasQ2026-10-2929
K240119Laminate Medical Technologies , Ltd.VasQ2024-02-1631

Recalls for QVQ devices

FDA recall records list no recalls for product code QVQ.

Frequently asked questions

What is FDA product code QVQ?

QVQ is the FDA product code for extravascular support for an arteriovenous fistula for vascular access. It is a Class II device, regulated under 21 CFR 870.4600 and reviewed by the Cardiovascular panel.

What device class is QVQ?

Class II, regulation 21 CFR 870.4600. Typical premarket route: 510(k).

How long does a 510(k) take for product code QVQ?

Across 2 cleared submissions the average was 30 days from receipt to decision (median 30).

Which companies have the most QVQ clearances?

Laminate Medical Technologies (1); Laminate Medical Technologies , Ltd. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times